273 related articles for article (PubMed ID: 7509898)
1. Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug.
Black SC; Butterfield JL; Lucchesi BR
J Cardiovasc Pharmacol; 1993 Dec; 22(6):810-8. PubMed ID: 7509898
[TBL] [Abstract][Full Text] [Related]
2. MS-551 protects against ventricular fibrillation in a chronic canine model of sudden cardiac death.
Friedrichs GS; Chi L; Gralinski MR; Black SC; Basler GC; Mu DX; Pewitt SR; Johnson CR; Lucchesi BR
J Cardiovasc Pharmacol; 1995 Feb; 25(2):314-23. PubMed ID: 7752658
[TBL] [Abstract][Full Text] [Related]
3. The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent.
Black SC; Chi LG; Mu DX; Lucchesi BR
J Pharmacol Exp Ther; 1991 Aug; 258(2):416-23. PubMed ID: 1865349
[TBL] [Abstract][Full Text] [Related]
4. Antifibrillatory efficacy of long-term tedisamil administration in a postinfarcted canine model of ischemic ventricular fibrillation.
Friedrichs GS; Abreu JN; Driscoll EM; Borlak J; Lucchesi BR
J Cardiovasc Pharmacol; 1998 Jan; 31(1):56-66. PubMed ID: 9456278
[TBL] [Abstract][Full Text] [Related]
5. HBI-3000 prevents secondary sudden cardiac death.
Lee JY; Lucchesi BR
J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):453-9. PubMed ID: 23615576
[TBL] [Abstract][Full Text] [Related]
6. Effects of azimilide, a new class III antiarrhythmic drug, on reentrant circuits causing ventricular tachycardia and fibrillation in a canine model of myocardial infarction.
Schmitt H; Cabo C; Coromilas JC; Wit AL
J Cardiovasc Electrophysiol; 2001 Sep; 12(9):1025-33. PubMed ID: 11573692
[TBL] [Abstract][Full Text] [Related]
7. Suppression of inducible ventricular arrhythmias by intravenous azimilide in dogs with previous myocardial infarction.
Drexler AP; Micklas JM; Brooks RR
J Cardiovasc Pharmacol; 1996 Dec; 28(6):848-55. PubMed ID: 8961084
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiology and antiarrhythmic actions of E-4031 in the experimental animal model of sudden coronary death.
Chi LG; Mu DX; Lucchesi BR
J Cardiovasc Pharmacol; 1991 Feb; 17(2):285-95. PubMed ID: 1709234
[TBL] [Abstract][Full Text] [Related]
9. Alinidine reduces the incidence of ischemic ventricular fibrillation in a conscious canine model, a protective effect antagonized by overdrive atrial pacing.
Uprichard AC; Chi LG; Lynch JJ; Driscoll EM; Frye JW; Lucchesi BR
J Cardiovasc Pharmacol; 1989 Sep; 14(3):475-82. PubMed ID: 2476629
[TBL] [Abstract][Full Text] [Related]
10. Effects of MS-551, a new class III antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, electrophysiology, and hemodynamics in a canine myocardial infarction model.
Kondoh K; Hashimoto H; Nishiyama H; Umemura K; Ozaki T; Uematsu T; Nakashima M
J Cardiovasc Pharmacol; 1994 Apr; 23(4):674-80. PubMed ID: 7516022
[TBL] [Abstract][Full Text] [Related]
11. Dose-Dependent Effects of Ranolazine on Reentrant Ventricular Arrhythmias Induced After Subacute Myocardial Infarction in Rabbits.
Moschovidis V; Simopoulos V; Stravela S; Dipla K; Hatziefthimiou A; Stamatiou R; Aidonidis I
J Cardiovasc Pharmacol Ther; 2020 Jan; 25(1):65-71. PubMed ID: 31242756
[TBL] [Abstract][Full Text] [Related]
12. Hypothyroidism renders protection against lethal ventricular arrhythmias in a conscious canine model of sudden death.
Venkatesh N; Lynch JJ; Uprichard AC; Kitzen JM; Singh BN; Lucchesi BR
J Cardiovasc Pharmacol; 1991 Nov; 18(5):703-10. PubMed ID: 1723767
[TBL] [Abstract][Full Text] [Related]
13. Suppression of lethal ischemic ventricular arrhythmias by the class III agent E4031 in a canine model of previous myocardial infarction.
Lynch JJ; Heaney LA; Wallace AA; Gehret JR; Selnick HG; Stein RB
J Cardiovasc Pharmacol; 1990 May; 15(5):764-75. PubMed ID: 1692937
[TBL] [Abstract][Full Text] [Related]
14. Tedisamil Attenuates Ventricular Fibrillation in a Conscious Canine Model of Sudden Cardiac Death.
Friedrichs GS; Abreu JN; Cousins GR; Chi L; Borlak J; Lucchesi BR
J Cardiovasc Pharmacol Ther; 1996 Oct; 1(4):313-324. PubMed ID: 10684432
[TBL] [Abstract][Full Text] [Related]
15. Effect of ajmaline on sustained ventricular tachycardia induced by programmed electrical stimulation in conscious dogs after myocardial infarction.
Todt H; Krumpl G; Zojer N; Krejcy K; Raberger G
Naunyn Schmiedebergs Arch Pharmacol; 1993 Sep; 348(3):290-7. PubMed ID: 7694159
[TBL] [Abstract][Full Text] [Related]
16. [Electrophysiological effects of neferine against ischemic ventricular tachyarrhythmias].
Guo Z
Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Apr; 20(2):119-22, 134. PubMed ID: 1473481
[TBL] [Abstract][Full Text] [Related]
17. 5-hydroxydecanoate fails to attenuate ventricular fibrillation in a conscious canine model of sudden cardiac death.
Friedrichs GS; Abreu JN; Black SC; Chi L; Lucchesi BR
Eur J Pharmacol; 1996 Jun; 306(1-3):99-106. PubMed ID: 8813621
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic and electrophysiologic actions of CK-3579 and sematilide in a conscious canine model of sudden coronary death.
Chi LG; Mu DX; Driscoll EM; Lucchesi BR
J Cardiovasc Pharmacol; 1990 Aug; 16(2):312-24. PubMed ID: 1697389
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic and electrophysiologic effects of bepridil in chronically infarcted conscious dogs.
Lynch JJ; Montgomery DG; Ventura A; Lucchesi BR
J Pharmacol Exp Ther; 1985 Jul; 234(1):72-80. PubMed ID: 3874285
[TBL] [Abstract][Full Text] [Related]
20. Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model.
Aidonidis I; Poyatzi A; Stamatiou G; Lymberi M; Stamatoyannis N; Molyvdas PA
J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):222-30. PubMed ID: 19587223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
